DiaCarta is a molecular diagnostics company that has developed innovative technologies that transform patient care by providing effective precision diagnostics using liquid biopsy. Well positioned as a leader in the emerging liquid biopsy field with its high-precision detection of cell free DNA, its novel XNA technology provides a high level of sensitivity as it clamps the wild-type sequence and amplifies the mutant target sequence.
The DiaCarta Clinical Laboratory that is certified by CLIA offers the following testing services as FDA EUA approved or Laboratory Developed Tests.
- FDA EUA approved QuantiVirus™ SARS-CoV-2 Tests
- Single-gene QClamp® qPCR tests -EGFR,KRAS,BRAF,NRAS,PIK3CA,C-KIT *
- OptiSeq™ PanCancer 65 Gene Panel *
- OptiSeq™ Colorectal Cancer NGS Panel*
- ColoScape™ – Colon Cancer Testing**
- RadTox™ cfDNA Radiation Response Test**
- Oncuria® Test **
* For research use only (RUO)
*Lab developed test (LDT)
